The Privatization of Cancer
In my forthcoming article, I argue that our cancer regulatory regimes inadequately protect the public.
Author
In my forthcoming article, I argue that our cancer regulatory regimes inadequately protect the public.
Daniel G. Aaron
During the coronavirus crisis, protesters are right that their liberty has been infringed. But the real cause is insufficient federal public health efforts.
Daniel G. Aaron
Coronavirus is an acute problem at the individual level, but nationally it represents a chronic concern.
Daniel G. Aaron
By Daniel Aaron This post is, in part, a response to a panel discussion on soda taxes and obesity, given by Professors Emily Broad Leib, Steven Gortmaker, and Carmel Shachar on February 14, 2020. Diet…
Daniel G. Aaron
By: Daniel Aaron Just last month, Professor Christopher T. Robertson, at the University of Arizona College of Law, released his new book about health care, entitled Exposed: Why Our Health Insurance Is Incomplete and What…
Daniel G. Aaron
By: Daniel Aaron Just last month, Professor Christopher T. Robertson, at the University of Arizona College of Law, released his new book about health care, entitled Exposed: Why Our Health Insurance Is Incomplete and What…
Daniel G. Aaron
By Daniel Aaron The Trump Administration has retreated from proposed tobacco regulations that experts generally agree would benefit public health. The regulations would have included a ban on flavored e-cigarettes, a favorite of children who…
Daniel G. Aaron
By Daniel Aaron In October, the Petrie-Flom Center hosted a conference of world-leading experts in HIV/AIDS to discuss one of the biggest public health successes in history: PEPFAR, the President’s Emergency Plan for AIDS Relief.…
Daniel G. Aaron
By Dan Aaron As the opioid litigation continues over the shadow of one of our nation’s most pressing public health crises, some criticism has been levied at private lawyers representing the cities, counties, states, and…
Daniel G. Aaron
By Daniel Aaron On October 21, two Ohio counties are slated to present their opioid claims in a federal trial. However, last week, 13 states and the District of Columbia signed onto a brief requesting…
Daniel G. Aaron